NCT02228668View on ClinicalTrials.gov

Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma

CompletedOBSERVATIONAL
Enrollment

1,636

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2019

Conditions
Colon Cancer Treated With Bevacizumab After Colon Surgery
Trial Locations (1)

Unknown

GERCOR, Paris

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

GERCOR - Multidisciplinary Oncology Cooperative Group

OTHER

NCT02228668 - Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma | Biotech Hunter | Biotech Hunter